Abstract:Abstract Background Hypokalemia is common in patients treated with antihypertensive drugs, but the impact of correcting hypokalemia is insufficiently studied. We examined the consequences of hypokalemia and borderline hypokalemia correction in patients with hypertension. Methods We identified 8976 patients with hypertension and plasma potassium concentrations ≤3.7 mmol/L within 100 days from combination antihypertensive therapy initiation. The first measurement between 6 and 100 days after the episode with potassium ≤3.7 mmol/L was retained. We investigated all-cause and cardiovascular mortality within 60-days from the second potassium measurement using Cox regression. Mortality was examined for seven predefined potassium intervals derived from the second measurement: 1.5–2.9 mmol/L ( n = 271), 3.0–3.4 mmol/L ( n = 1341), 3.5–3.7 ( n = 1982) mmol/L, 3.8–4.0 mmol/L ( n = 2398, reference), 4.1–4.6 mmol/L ( n = 2498), 4.7–5.0 mmol/L ( n = 352) and 5.1–7.1 mmol/L ( n = 134). Results Multivariable analysis showed that potassium concentrations 1.5–2.9 mmol/L, 3.0–3.4 mmol/L, 4.7–5.0 mmol/L and 5.1–7.1 mmol/L were associated with increased all-cause mortality (HR 2.39, 95% CI 1.66–3.43; HR 1.36, 95% CI 1.04–1.78; HR 2.36, 95% CI 1.68–3.30 and HR 2.62, 95% CI 1.73–3.98, respectively). Potassium levels 4.6 mmol/L were associated with increased cardiovascular mortality. The adjusted standardized 60-day mortality risks in the seven strata were: 11.7% (95% CI 8.3–15.0%), 7.1% (95% CI 5.8–8.5%), 6.4% (95% CI 5.3–7.5%), 5.4% (4.5–6.3%), 6.3% (5.4–7.2%), 11.6% (95% CI 8.7–14.6%) and 12.6% (95% CI 8.2–16.9%), respectively. Conclusions Persistent hypokalemia was frequent and associated with increased all-cause and cardiovascular mortality. Increase in potassium to levels > 4.6 mmol/L in patients with initial hypokalemia or low normal potassium was associated with increased all-cause and cardiovascular mortality.

Serum potassium changes during hypothermia and rewarming: a case series and hypothesis on the mechanism

Serum Potassium Levels and Mortality in Hospitalized Heart Failure Patients

Effect of Dynamic Potassium Change on In-Hospital Mortality, Ventricular Arrhythmias, and Long-Term Mortality in STEMI

[Lymph node enlargement from the internistis viewpoint].

Serum Potassium in Thyroid Cancer Patients With Hypothyroidism During Thyroid Hormone Withdrawal: A Retrospective Study

Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium

Potential medical impact of unrecognized in vitro hypokalemia due to hemolysis: a case series

Association of serum potassium with decline in residual kidney function in incident hemodialysis patients

Determinants of hypokalemia following hypertonic sodium bicarbonate infusion

Evaluation of an Intravenous Potassium Dosing Algorithm for Hypokalemic Critically Ill Patients

Serum Potassium Disorders Predict Subsequent Kidney Injury: A Retrospective Observational Cohort Study of Hospitalized Patients

Hyperkalemia: Pharmacotherapies and Clinical Considerations

Radiology of the resurfaced hip

Serum potassium levels and outcomes in critically ill patients in the medical intensive care unit

Double Trouble of Severe Hyperkalemia: Syncope and No Significant ECG Changes

Hypokalemia-Induced Arrhythmia: A Case Series and Literature Review

Clinical Outcomes by Serum Potassium Levels for Patients Hospitalized for Heart Failure: Secondary Analysis of Data from the China National Heart Failure Registry.

Ultrasonic treatment of biological sludge: Floc disintegration, cell lysis and inactivation.

[Epidemiological studies of the incidence of the rheumatoid factor in a community of aged subjects].

Impact of Different Serum Potassium Levels on Postresuscitation Heart Function and Hemodynamics in Patients with Nontraumatic Out-of-Hospital Cardiac Arrest

Maximum serum K+ concentration within 1 hour with enteral replacement in severe hypokalemia